 |
[엠디데일리] The Ministry of Food and Drug Safety (Director Kang-Rip Kim) announced on February 3 that it had approved the special import of Pfizer’s Corona 19 vaccine’Cominatiju’, which is expected to be supplied from COVAX FACILITY.
This special import was made at the request of the Korea Centers for Disease Control and Prevention after a joint expert advisory meeting between the Ministry of Food and Drug Safety and the Korean Disease Administration. It is expected to be imported in Korea from mid-February through the center.
The Ministry of Food and Drug Safety decided to approve this special case by comprehensively considering the opinions of the joint expert advisory meeting and overseas vaccination cases in order to secure public safety through vaccination.
As for the quality of vaccines, as soon as the quantity is confirmed after special approval, and a test report for the quantity is secured, we plan to discuss the quality verification method with the Agency for Disease Control and Prevention.
In the future, the government will make every effort to ensure that the COVAX-Pfizer Corona 19 vaccine can be supplied without disruption to the vaccination implementation plan, while the vaccine will be used safely through appropriate and prompt measures if necessary through thorough monitoring of abnormal cases after vaccination. He said he would do his best to help.
Reporter Lee Young-bok 48yblee
<저작권자 © 엠디저널, 무단 전재 및 재배포 금지>